To examine the risk of hepatitis C virus (HCV) transmission between patient
s infected with HCV and their household members (siblings, offspring and pa
rents), as well as their stable heterosexual partners, a systematic search
of the MEDLINE database was undertaken for all relevant articles published
up to June 1997. English language publications or those supplemented with a
n English abstract that reported studies concerning hepatitis C, and househ
old, intrafamilial, sexual and intraspousal transmission of HCV, were revie
wed. Data from uncontrolled and controlled studies were collected and analy
sed separately. Studies reporting the exclusive use of first-generation ant
i-HCV antibodies without supplemental tests were excluded. Pre- or postnata
l mother-to-child transmission of HCV and homosexual and heterosexual trans
mission of HCV among non-permanent couples were not included. Unweighted da
ta from individual studies were pooled for each category of family member.
Data were also analysed separately for Japanese and non-Japanese studies be
cause there is evidence that intrafamilial transmission may differ, based o
n endemicity of the viral infection. Comparisons were drawn only from contr
olled studies that reported the prevalence of HCV in family members of both
HCV-positive and HCV-negative controls. Pooled odds ratios (OR) and 95% co
nfidence intervals (CI) were calculated for each family category. In uncont
rolled studies, the pooled prevalence of anti-HCV among 4250 stable sexual
contacts of patients with HCV-related chronic liver disease (CLD) was 13.48
%, while the pooled prevalence of anti-HCV among 580 stable sexual contacts
of patients who contracted HCV as a result of multiple transfusions was 2.
41%. In controlled studies, the pooled prevalence of anti-HCV among 175 sib
lings and household contacts of patients with CLD was 4.0% compared with 0%
among 109 contacts of anti-HCV-negative controls (OR 9.75, 95% CI 0.91 ad
infinitum). The pooled prevalence of anti-HCV among offspring of Japanese H
CV-infected CLD patients was 17% compared with 10.4% among offspring of HCV
-negative Japanese controls (OR 1.77, 95% CI 1.21-2.58, P=0.002). The poole
d prevalence of anti-HCV among spouses of non-Japanese HCV-infected CLD pat
ients was 15.2% compared with 0.9% in the spouses of non-Japanese HCV-negat
ive controls (OR 20.57, 95% CI 6.05-84.08, P=0.0001). The prevalence of ant
i-HCV among non-Japanese offspring and Japanese spouses of HCV-infected pat
ients was not increased compared with controls. HCV genotype homology and m
utant analysis studies in pairs of HCV-infected patients and their HCV-infe
cted contacts showed that concordant genotype homology was found in 66% of
non-sexual contacts and in 74% of sexual contacts. Sequence homology of gre
ater than 92% was found in 19 out of 35 pairs. Hence, evidence exists that
familial, non-sexual and sexual transmission of HCV does occur. In Japanese
patients, transmission probably occurs in younger family members while, in
non-Japanese patients, transmission probably occurs at an older age, after
contact with an HCV-infected spouse.